TLR4 and neoplasm: Specifically, F. nucleatum can activate TLR4 signaling to promote tumor development, and another over-presented bacterium, Peptostreptococcus anaerobius, can promote carcinogenesis by activating TLR2 and/or the TLR4 pathway in patients with CRC.